Aspira Women's Health Inc. 10-K filing
Filed 2026-04-01 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0000926617-26-000020
- Form type
- 10-K
- CIK
- 0000926617
- Primary document
- https://www.sec.gov/Archives/edgar/data/926617/000092661726000020/awhl-20251231x10k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aspira Women's Health Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Total Liabilities | $12.4M | - | - |
| Shareholders Equity | $-6.9M | - | - |
| Operating Cash Flow | $-7.0M | - | - |
| Capital Expenditures | $16,000 | - | - |
| Revenue | $9.2M | - | - |
| Cost Of Revenue | $3.3M | - | - |
| Gross Profit | $5.9M | - | - |
| Operating Income | $-7.9M | - | - |
| Net Income | $-12.8M | - | - |
| Eps Basic | -0.37 | - | - |
| Eps Diluted | -0.37 | - | - |
| Cash And Equivalents | $1.8M | - | - |
| Total Assets | $5.5M | - | - |